Vedolizumab is a monoclonal antibody used to treat inflammatory bowel diseases like Crohn's disease and ulcerative colitis. It works by inhibiting the migration of inflammatory cells to the gut, reducing inflammation. This medication is essential for managing chronic gastrointestinal conditions. In summary, Vedolizumab is effective in treating inflammatory bowel diseases.
Vedolizumab binds to the α4β7 integrin on lymphocytes, preventing their adhesion to the gut's endothelial cells and reducing inflammation.
No published brands for this salt yet.